167 related articles for article (PubMed ID: 38390209)
1. Comparative prognosis and risk assessment in gallbladder neuroendocrine neoplasms versus adenocarcinomas.
Zhao ZH; Huang Y; Jiang C; Lv GY; Wang M
Front Endocrinol (Lausanne); 2024; 15():1326112. PubMed ID: 38390209
[TBL] [Abstract][Full Text] [Related]
2. Nomograms for Predicting Survival Outcomes in Patients with Neuroendocrine Neoplasms of the Gallbladder Undergoing Primary Tumor Resection: A Population-Based Study.
Zhang YR; Hu GC; Fan MK; Yao HL; Jiang C; Shi HY; Lin R
Curr Oncol; 2023 Feb; 30(3):2889-2899. PubMed ID: 36975434
[TBL] [Abstract][Full Text] [Related]
3. The clinical and prognostic factors for biliary neuroendocrine neoplasm: a study based on the SEER database.
Zheng BH; Zhang C; Wan WZ; Sun WT; Cheng X; Ni XJ; Ni XL; Suo T; Liu H; Shen S; Liu HB
BMC Surg; 2022 Jun; 22(1):253. PubMed ID: 35768809
[TBL] [Abstract][Full Text] [Related]
4. A Nomogram to Predict Individual Survival of Patients with Liver-Limited Metastases from Gastroenteropancreatic Neuroendocrine Neoplasms: A US Population-Based Cohort Analysis and Chinese Multicenter Cohort Validation Study.
Xu G; Xiao Y; Hu H; Jin B; Wu X; Wan X; Zheng Y; Xu H; Lu X; Sang X; Ge P; Mao Y; Cai J; Zhao H; Du S
Neuroendocrinology; 2022; 112(3):263-275. PubMed ID: 33902058
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the Clinical Features and Outcomes of Gallbladder Neuroendocrine Carcinoma with Those of Adenocarcinoma: A Propensity Score-Matched Analysis.
Do MY; Jang SI; Kang HP; Kim EJ; Lee KJ; Park GE; Lee SJ; Lee DK; Woo SM; Cho JH
Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572940
[TBL] [Abstract][Full Text] [Related]
6. Biliary Neuroendocrine Neoplasms: Analysis of Prognostic Factors and Development and Validation of a Nomogram.
Zhou S; Jiang S; Chen W; Yin H; Dong L; Zhao H; Han S; He X
Front Oncol; 2021; 11():654439. PubMed ID: 34350109
[TBL] [Abstract][Full Text] [Related]
7. Differential and prognostic MRI features of gallbladder neuroendocrine tumors and adenocarcinomas.
Bae JS; Kim SH; Yoo J; Kim H; Han JK
Eur Radiol; 2020 May; 30(5):2890-2901. PubMed ID: 32025835
[TBL] [Abstract][Full Text] [Related]
8. Neuroendocrine neoplasms of the gallbladder: early detection and surgery is key to improved outcome.
Gogna S; Samson D; Gachabayov M; Rojas A; Felsenreich DM; Koo D; Gu K; Quintero L; Miller KR; Azim A; Da Eric Dong X
Langenbecks Arch Surg; 2022 Feb; 407(1):197-206. PubMed ID: 34236488
[TBL] [Abstract][Full Text] [Related]
9. Incidence and survival trends for gastric neuroendocrine neoplasms: An analysis of 3523 patients in the SEER database.
Cao LL; Lu J; Lin JX; Zheng CH; Li P; Xie JW; Wang JB; Chen QY; Lin M; Tu RH; Huang CM
Eur J Surg Oncol; 2018 Oct; 44(10):1628-1633. PubMed ID: 29983275
[TBL] [Abstract][Full Text] [Related]
10. A prognostic nomogram based on log odds of positive lymph nodes to predict the overall survival in biliary neuroendocrine neoplasms (NENs) patients after surgery.
Jiang S; Yang F; Zhang L; Sang X; Lu X; Zheng Y; Xu Y
J Endocrinol Invest; 2022 Dec; 45(12):2341-2351. PubMed ID: 35908009
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of prognostic nomograms for patients with colon neuroendocrine neoplasms.
Xu R; Zhou B; Hu P; Xue B; Gu D; Li X; Tang Q
World J Surg Oncol; 2021 Aug; 19(1):233. PubMed ID: 34364382
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of a nomogram for predicting the overall survival of patients with gastroenteropancreatic neuroendocrine neoplasms.
Xie S; Li L; Wang X; Li L
Medicine (Baltimore); 2021 Jan; 100(2):e24223. PubMed ID: 33466202
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of a prognostic nomogram for gallbladder papillary adenocarcinoma.
Wang Z; Wang L; Hua Y; Zhuang X; Bai Y; Wang H
Front Oncol; 2023; 13():1157057. PubMed ID: 37260969
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive Clinical Analysis of Gallbladder Neuroendocrine Neoplasms: A Large-Volume Multicenter Study During One Decade.
Wang Y; Huang B; Fu Q; Wang J; Ye M; Hu M; Qu K; Liu K; Hu X; Wei S; Sun K; Xiao W; Zhang B; Li H; Li J; Zhang Q; Liang T
Ann Surg Oncol; 2022 Nov; 29(12):7619-7630. PubMed ID: 35849293
[TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics analysis and prognostic nomogram for predicting survival in patients with second primary prostate cancer: a population study based on SEER database.
Deng R; Zhou J; Qiu J; Cai L; Gong K
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11791-11806. PubMed ID: 37405473
[TBL] [Abstract][Full Text] [Related]
16. Development and Validation of Prognostic Nomograms for Periampullary Neuroendocrine Neoplasms: A SEER Database Analysis.
Chen J; Chen Q; Deng Y; Jiang Y; Huang Z; Zhou J; Zhao H; Cai J
Curr Oncol; 2022 Dec; 30(1):344-357. PubMed ID: 36661677
[TBL] [Abstract][Full Text] [Related]
17. Nomogram individually predicts the overall survival of patients with gastroenteropancreatic neuroendocrine neoplasms.
Fang C; Wang W; Feng X; Sun J; Zhang Y; Zeng Y; Wang J; Chen H; Cai M; Lin J; Chen M; Chen Y; Li Y; Li S; Chen J; Zhou Z
Br J Cancer; 2017 Nov; 117(10):1544-1550. PubMed ID: 28949958
[TBL] [Abstract][Full Text] [Related]
18. Development and Validation of Prognostic Nomograms for Patients with Duodenal Neuroendocrine Neoplasms.
Sun S; Wang W; He C
Med Sci Monit; 2020 Jun; 26():e922613. PubMed ID: 32564052
[TBL] [Abstract][Full Text] [Related]
19. Epidemiological trends and novel prognostic evaluation approaches of patients with stage II-IV colorectal neuroendocrine neoplasms: A population-based study with external validation.
Zhao F; Huang L; Wang Z; Wei F; Xiao T; Liu Q
Front Endocrinol (Lausanne); 2023; 14():1061187. PubMed ID: 36817582
[TBL] [Abstract][Full Text] [Related]
20. Risk and prognostic nomograms for colorectal neuroendocrine neoplasm with liver metastasis: a population-based study.
Ding X; Tian S; Hu J; Wang G; Yu X; Fu D; Yuan Y; Wang L; Wang Z
Int J Colorectal Dis; 2021 Sep; 36(9):1915-1927. PubMed ID: 34061225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
